Schrödinger Promotes Therese Abrams to Principal Accounting Officer
TipRanks (Thu, 12-Mar 4:31 PM ET)
SDGR’s ACV Growth and Hosted Software Shift Target Predictable Revenue and EBITDA Turnaround
Market Chameleon (Thu, 26-Feb 6:38 AM ET)
Market Chameleon (Thu, 26-Feb 2:38 AM ET)
Schrdinger Reports Fourth Quarter and Full-Year 2025 Financial Results
Business Wire (Wed, 25-Feb 4:05 PM ET)
Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Business Wire (Wed, 18-Feb 8:30 AM ET)
Schrdinger to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 25
Business Wire (Wed, 11-Feb 8:30 AM ET)
Schrdinger Provides Update on Progress Across the Business and Outlines 2026 Strategic Priorities
Business Wire (Mon, 12-Jan 8:30 AM ET)
Schrdinger Partners with Lilly to Make TuneLab Platform Available in LiveDesign
Business Wire (Fri, 9-Jan 7:00 AM ET)
Market Chameleon (Thu, 6-Nov 4:34 AM ET)
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.
Schrodinger trades on the NASDAQ stock market under the symbol SDGR.
As of March 12, 2026, SDGR stock price declined to $12.16 with 1,107,208 million shares trading.
SDGR has a beta of 1.77, meaning it tends to be more sensitive to market movements. SDGR has a correlation of 0.26 to the broad based SPY ETF.
SDGR has a market cap of $892.23 million. This is considered a Small Cap stock.
Last quarter Schrodinger reported $87 million in Revenue and -$.19 earnings per share. This beat revenue expectation by $4 million and missed earnings estimates by -$.08.
In the last 3 years, SDGR traded as high as $59.24 and as low as $11.11.
The top ETF exchange traded funds that SDGR belongs to (by Net Assets): IJR, VTI, ARKG, VB, IWM.
SDGR has underperformed the market in the last year with a return of -43.9%, while the SPY ETF gained +21.1%. In the last 3 month period, SDGR fell short of the market, returning -32.9%, while SPY returned -3.1%. However, in the most recent 2 weeks SDGR has outperformed the stock market by returning +3.1%, while SPY returned -3.9%.
SDGR support price is $12.23 and resistance is $13.24 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SDGR shares will trade within this expected range on the day.
